Competitor Analysis availables at pipeline stores

Newsletters

Weekly newsletter focused on antibodies, proteins & peptides, gene therapy, RNA and cell therapy, vaccines, biogenerics and related business. It contains brief abstracts of preclinical & clinical studies, regulatory updates and company news of the previous week, but for biologics only. Subscribe Now

Consultancy

Need consultancy on this topic? La Merie SL provides consultancy services to all clients who wish a fully personal, individual, strictly confidential and exclusive collaboration on a specific subject.

Thrombolytics Agents

 

Thrombolytics

Competitor Analysis availables at Pipelinereview.com

Need consultancy on this topic?

The Competitive Intelligence Report Thrombolytics as of April 2007 provides a competitor analysis in the development pipeline of novel projects acting as 4 th generation plasminogen activators or as directly acting fibrinolytics such as plasmin and includes variants and engineered proteins. Thrombolytics are established treatments of acute myocardial infarction and also used in stroke and for catheter clearance. Novel thrombolytics are being evaluated for acute peripheral arterial occlusive disease, visual disorders such as vitreolysis and diabetic retinopathy, and neuroprotection in acute ischemic stroke and deep vein thrombosis. Numerous companies in “off-patent” countries have developed recombinant and biosimilar thrombolytics and introduced them into the market.

 

Buy now a Competitor Analysis on:
Thrombolytics